Bleeding and Clotting Disorders Institute — Peoria, Illinois

Bleeding and Clotting Disorders Institute is a clinical research site located in Peoria, Illinois, United States 61614-2868.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

Bleeding and Clotting Disorders Institute has participated in 24 clinical trials with 6 currently active.

Therapeutic areas: Immune Thrombocytopenia, Acquired Hemophilia A, Von Willebrand Disease, Type 3.

Sponsors: Principia Biopharma, a Sanofi Company, Baxalta now part of Shire, Bleeding and Clotting Disorders Institute Peoria, Illinois.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Peoria

Browse all research sites in Illinois · View every site in Peoria

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Bleeding and Clotting Disorders Institute?

Bleeding and Clotting Disorders Institute has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Bleeding and Clotting Disorders Institute conducted?

Bleeding and Clotting Disorders Institute has 24 clinical trials on record, with 6 currently active. Their work covers Immune Thrombocytopenia, Acquired Hemophilia A, Von Willebrand Disease, Type 3.

Is Bleeding and Clotting Disorders Institute accredited by Crixeo Clinical Trials?

Bleeding and Clotting Disorders Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Bleeding and Clotting Disorders Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.